跳至主要内容
临床试验/IRCT20230116057135N1
IRCT20230116057135N1尚未招募3 期

Evaluation of NBS herbal powder effects as a complementary medicine on the recovery of patients with multi-drug resistant tuberculosis

Tehran University of Medical Sciences0 个研究点目标入组 88 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募
入组人数
88

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • Patients with multi-drug resistant tuberculosis
  • Patients over 18 years old

排除标准

  • The patient's withdrawal from the study
  • Patients with any other chronic disease such as diabetes, cardiovascular disease, etc.
  • Patients who have received supplements of vitamin D, zinc, B vitamins and other micronutrients in the last month.
  • Patients who do not come for follow-up treatment at specified intervals
  • Pregnant and lactating mothers
  • Use of corticosteroids and immunosuppressive drugs
  • Observing any drug sensitivity (especially digestive sensitivity to gluten) as determined by the attending physician
  • Deterioration of the patient's clinical symptoms due to the consumption of Nutrition Bio-Shield (NBS) powder, as determined by the attending physician
  • Patient's death during common and selective treatments (in case of death, the patient's information is fully recorded and laboratory tests are performed along with other samples to determine the possible effect of the drug on the patient's death)

研究者

相似试验